Definitive Healthcare (DH) Projected to Post Earnings on Thursday

Definitive Healthcare (NASDAQ:DH) is expected to post its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect Definitive Healthcare to post earnings of $0.06 per share and revenue of $59.5090 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Thursday, November 6, 2025 at 5:00 PM ET.

Definitive Healthcare Price Performance

Shares of NASDAQ:DH opened at $2.77 on Thursday. The company has a market capitalization of $396.50 million, a P/E ratio of -1.05 and a beta of 1.65. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.65 and a current ratio of 1.65. Definitive Healthcare has a fifty-two week low of $2.15 and a fifty-two week high of $5.68. The company’s 50-day moving average is $3.63 and its 200 day moving average is $3.56.

Institutional Trading of Definitive Healthcare

A number of large investors have recently modified their holdings of DH. Caxton Associates LLP purchased a new stake in Definitive Healthcare in the second quarter valued at approximately $308,000. Tower Research Capital LLC TRC increased its holdings in shares of Definitive Healthcare by 357.5% in the 2nd quarter. Tower Research Capital LLC TRC now owns 17,233 shares of the company’s stock worth $67,000 after buying an additional 13,466 shares during the last quarter. Engineers Gate Manager LP purchased a new position in Definitive Healthcare in the second quarter worth $292,000. Brevan Howard Capital Management LP grew its position in Definitive Healthcare by 635.0% in the second quarter. Brevan Howard Capital Management LP now owns 112,124 shares of the company’s stock worth $437,000 after acquiring an additional 96,869 shares in the last quarter. Finally, Bank of America Corp DE raised its holdings in shares of Definitive Healthcare by 23.7% during the 2nd quarter. Bank of America Corp DE now owns 769,397 shares of the company’s stock valued at $3,001,000 after buying an additional 147,599 shares in the last quarter. Institutional investors own 98.67% of the company’s stock.

Analyst Ratings Changes

DH has been the subject of several research analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of Definitive Healthcare in a research note on Wednesday, October 8th. Robert W. Baird set a $4.00 price target on Definitive Healthcare in a research report on Friday, August 8th. Finally, Stifel Nicolaus upped their price target on Definitive Healthcare from $5.00 to $6.00 and gave the company a “buy” rating in a research report on Friday, August 8th. One equities research analyst has rated the stock with a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, Definitive Healthcare presently has a consensus rating of “Reduce” and a consensus target price of $4.28.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.